iPhone app iPad app Android phone app Android tablet app

Pharmaceutical Industry

Five Legislators I May Not Vote For Again

Bruce Tenenbaum | Posted 08.01.2011 | Politics
Bruce Tenenbaum

This past month, my health insurance company raised premiums across the board 34%. The Democrats are already making noise about giving in to the insurance business. Why, then, did any of us vote for these fools?

Recession Pushing Cost of Drugs Out of Reach

nytimes.com | KEVIN SACK | Posted 05.25.2011 | Business

OCKY MOUNT, N.C. -- A year or so ago, when customers buttonholed the pharmacists at Almand's Drug Store here the questions were invariably about dosin...

Pharmaceutical Drug Pushers Lead to National Overdose

Francesca Biller | Posted 05.25.2011 | Politics
Francesca Biller

I only hope that some woman is lucky enough to be with a man who becomes afflicted with one side effect Viagra claims, a condition known as priapism, ...

Old Drug, New Drug . . . Red Drug, Blue Drug?

James S. Gordon | Posted 05.25.2011 | Green
James S. Gordon

This letter of mine appeared in The New York Times yesterday (in somewhat shortened form), under the title, "Alternatives to New Drugs." I thought yo...

Could Heath Care Reform's Success Bring Failure Again?

Sheri and Allan Rivlin | Posted 05.25.2011 | Politics
Sheri and Allan Rivlin

Many veteran Washington watchers are starting to assume that there will be some health care reform this year, but the real question is whether it will include a government option.

Universal Health Care Can Save Our Economy and Keep 1.7 million Jobs in the U.S.: Part III

Dr. Behzad Mohit | Posted 05.25.2011 | Business
Dr. Behzad Mohit

What can we do to keep U.S. automakers and other manufacturers in the country? Could instituting universal health care help?

The Swine Flu or the FDA: Which Is More Dangerous to Your Health?

John W. Whitehead | Posted 11.17.2011 | Healthy Living
John W. Whitehead

News media sycophants have taken up the hew and cry over Tamiflu's life-saving properties. Yet little is being said about the very real dangers that these drugs pose to your health and mental welfare.

Vitamins: Eyeballing our Sacred Cows

Kathleen Slattery-Moschkau | Posted 05.25.2011 | Media
Kathleen Slattery-Moschkau

I shared the New York Times article on Vitamins not because I think the information is Gospel but because it raised interesting questions about a few of our very closely held assumptions.

Merck sees 57 percent drop in first-quarter profit

AP | LINDA A. JOHNSON | Posted 05.25.2011 | Business

TRENTON, N.J. — Drugmaker Merck & Co. on Tuesday posted a 57 percent drop in first-quarter profit, falling short of expectations and sending its...

US Water Contaminated By Pharmaceutical Companies, Hospitals, Consumers

AP | JEFF DONN, MARTHA MENDOZA and JUSTIN PRITCHARD | Posted 05.25.2011 | Green

U.S. manufacturers, including major drugmakers, have legally released at least 271 million pounds of pharmaceuticals into waterways that often provide...

America's Self-Defeating Attitude on Health Care Reform

Sahil Kapur | Posted 05.25.2011 | Politics
Sahil Kapur

The current system encourages exclusion of those who need medical care the most, and only government has the power to restructure these incentives.

Is Katherine Heigl Really Such a %$#@!

Kathleen Slattery-Moschkau | Posted 05.25.2011 | Entertainment
Kathleen Slattery-Moschkau

For 16 days Katherine, I and the rest of the crew worked 12 to 14 hours a day. She napped on my couch, she played with my kids, she knitted on my porch. She even wore my underwear.

Online Age Quiz Useful For Drug Makers

New York Times | STEPHANIE CLIFFORD | Posted 05.25.2011 | Business

Americans yearn to be young. So it is little wonder that RealAge, which promises to help shave years off your age, has become one of the most popular ...

Pharma: Still Chasing Skirts

Kathleen Slattery-Moschkau | Posted 05.25.2011 | Business
Kathleen Slattery-Moschkau

As someone who spent ten years inside the pharmaceutical industry, I can tell you one thing for sure: Big Pharma goes where the money is. And the money is with the ladies.

Wyeth Loses Supreme Court Case, Opens Consumer Suits Against Pharma

Reuters | Lisa Richwine and James Vicini | Posted 05.25.2011 | Business

WASHINGTON (Reuters) -- The U.S. Supreme Court ruled against the drugmaker Wyeth on Wednesday, holding that pharmaceutical companies can be held liabl...

Medical School Ethics At Issue

New York Times | DUFF WILSON | Posted 05.25.2011 | Business

UPDATE: Senator Charles E. Grassley on Tuesday asked the drug maker Pfizer to provide details of its payments to at least 149 faculty members at Harva...

Orrin Hatch's Charity Recieved Mass Sums From Drug Companies He Passed Legislation For

Washington Times | Posted 05.25.2011 | Politics

The pharmaceutical industry that long has benefited from Sen. Orrin G. Hatch´s legislative efforts has directed large sums of money to a charity he h...

Pharmaceutical Mergers Considered

New York Times | NATASHA SINGER and DUFF WILSON | Posted 05.25.2011 | Business

Sports fans have fantasy baseball. Drug industry analysts have fantasy mergers. In the pharmaceutical version of the game, analysts use balance she...

CNN's Gupta: Not What the Doctor Ordered

James Floyd, M.D. | Posted 05.25.2011 | Politics
James Floyd, M.D.

Gupta downplays safety risks in treatments, and was criticized for his reporting on Vioxx, a pain medication that was withdrawn from the market in 2004 because it causes heart attacks.

Innovations in Phase IV Clinical Trials for Change in Health Care

Sunil Chacko | Posted 05.25.2011 | Politics
Sunil Chacko

For dying patients with no therapy that is working, compassionate use programs exist to provide drugs in phase II or III clinical trials when the patient was ineligible to participate in the trial.

Pfizer To Buy Wyeth For $68 Billion

AP | LINDA A. JOHNSON | Posted 05.25.2011 | Business

TRENTON, N.J. — Pfizer Inc., the world's largest drugmaker, said Monday it is buying rival Wyeth for $68 billion in a deal that will quickly boo...

Pfizer, Wyeth In Talks For $60B Merger

Wall Street Journal | MATTHEW KARNITSCHNIG and JONATHAN D. ROCKOFF | Posted 05.25.2011 | Business

Pfizer Inc. is in talks to acquire rival drug maker Wyeth in a deal that could be valued at more than $60 billion, said people familiar with the matte...

A New Year's Resolution for the FDA: Kick the Drug (Company) Addiction

Jeanne Lenzer and Shannon Brownlee | Posted 05.25.2011 | Politics
Jeanne Lenzer and Shannon Brownlee

The FDA needs to admit that it is currently powerless over the industry it is supposed to be regulating; it has let Big Pharma take over and become dependent on drug company money.

Merck To Slash 7,200 Jobs Following 3Q Net Drop Of 28 Percent

AP | LINDA A. JOHNSON | Posted 05.25.2011 | Business

TRENTON, N.J. — Drugmaker Merck & Co. said Wednesday it will slash 7,200 jobs as part of a new restructuring program that comes as its third-qua...

Illinois Nets $3M In Pfizer Settlement

AP | Posted 05.25.2011 | Chicago

(AP) -- Attorney General Lisa Madigan says Illinois will receive $3 million from a $60 million settlement with Pfizer over the marketing of the drug m...